Q: On Fast Money's Trader Radar we look at the stock that was lighting up screens across Wall Street today. Its much-lauded little blue pill hasn't been able to prop up shares this year, as the stock flags in the face of pipeline problems and generic competition. But after setbacks for a competitor's cholesterol drug, investors are betting Thursday's earnings report will show stronger Lipitor sales for the world's biggest drugmaker.
A: Pfizer is on the Trader Radar tonight! Shares of this pharmaceutical company were among the most actively traded on the NYSE today.